Caribou Biosciences, Inc. (CRBU) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Steven Kanner

Chief Scientific Officer

$40.58K (3)

$490.03K (2) scheduled

−$449.46K

431,556

0.4025%

$832.90K

+283.1%

Ryan Fischesser

VP of Finance and Controller

$37.31K (4)

$107.96K (1) scheduled

−$70.65K

118,854

0.1109%

$229.39K

+51.4%

Syed Ali-aamir Rizvi

Chief Medical Officer

—

$35.51K (1)

−$35.51K

59,373

0.0554%

$114.59K

+1,087%

Sriram Ryali

Chief Financial Officer

$24.65K (1)

—

+$24.65K

72,360

0.0675%

$139.65K

—

Barbara G McClung

Chief Legal Officer

$41.28K (4)

$18.41K (2)

+$22.87K

481,564

0.4492%

$929.42K

+44.3%

Rachel E. Haurwitz

President and CEO

$20.40K (1)

—

+$20.40K

3,816,545

3.56%

$7.37M

+13.9%

Ruhi Ahmad Khan

Chief Business Officer

—

$18.41K (2)

−$18.41K

104,998

0.0979%

$202.65K

—

Timothy P Kelly

Chief Technology Officer

—

$18.19K (2)

−$18.19K

73,125

0.0682%

$141.13K

—

Tina M. Albertson

Chief Medical Officer

—

$2.09K (1) scheduled

−$2.09K

68,523

0.0639%

$132.25K

—

Fmr LLC entity

See Remark 1

—

3,323,284

3.10%

$6.41M

—

Jason O'Byrne

Chief Financial Officer

—

59,224

0.0552%

$114.30K

+3,037%

Caribou Biosciences, Inc.

What the insiders did Net buying

By person